You are here

cancer

At 2020 deadline, progress in Patrick Soon-Shiong’s ‘cancer moonshot’ is hard to find

Stat

Wed, 01/8/20 - 12:12 pm

Dr. Patrick Soon-Shiong

clinical trials

US cancer death rate drops by sharpest rate on record

BioPharma Dive

Wed, 01/8/20 - 12:06 pm

Bristol-Myers Squibb

Verastem pens KRAS-focused drug licensing deal with Chugai

Fierce Biotech

Wed, 01/8/20 - 10:34 am

Drug developers take fresh aim at 'guided-missile' cancer drugs

Reuters

Mon, 01/6/20 - 10:38 am

drug development

antibody-drug conjugate

The first biotech IPO of the new decade has landed — and of course it's another cancer drug developer

Endpoints

Mon, 01/6/20 - 10:27 am

Black Diamond Therapeutics

I-Mab Biopharma

3 Blockbuster Cancer Drug Launches to Watch in 2020

Motley Fool

Thu, 01/2/20 - 11:57 pm

Seattle Genetics

Takeda Strikes Potential $1 Billion Oncology Deal with Turnstone

BioSpace

Thu, 12/19/19 - 12:56 pm

Turnstone Biologics

When FDA Requires Pediatric Studies for New Cancer Drug Submissions: New Draft Guidance

RAPS.org

Thu, 12/12/19 - 05:27 pm

pediatric cancer

Vedanta Biosciences initiates first-in-patient study of VE800 in combination with Bristol-Myers Squibb’s Opdivo

Pharmaceutical Business Review

Wed, 12/11/19 - 10:10 am

Vedanta Biosciences

Bristol-Myers Squibb

clinical trials

AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis

BioSpace

Mon, 12/9/19 - 11:18 pm

Scripps Research Institute

ASH19: AZ’s Calquence throws gauntlet down to Imbruvica

Pharmaforum

Sun, 12/8/19 - 10:17 pm

Why The Obsession With A Universal Cure For Cancer May Be Harming Research And Patients

Forbes

Sun, 12/8/19 - 10:15 pm

universal cancer vaccine

Lilly puts its cancer future in Loxo's hands

Biopharma Dive

Thu, 12/5/19 - 10:20 am

How a New Method is Improving Whole Genome Sequencing of FFPE Tumor Tissues

Xtalks

Tue, 12/3/19 - 10:31 am

genome sequencing

Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio

Fierce Pharma

Tue, 12/3/19 - 10:02 am

Another cancer vaccine play out of Geneva shoots for 'hard endpoint' in PhII head and neck cancer test

Endpoints

Tue, 11/26/19 - 10:32 am

cancer vaccines

head and neck cancer

Teva forms academic R&D pacts to further biopharma strategy

Fierce Biotech

Tue, 11/26/19 - 10:21 am

Teva Pharmaceutical

2 Small-Cap Biotechs That Soared Last Week

Motley Fool

Tue, 11/26/19 - 09:42 am

Magenta Therapeutics

Molecular Templates

AstraZeneca CEO: Closing In On A Cancer Cure

Yahoo/Benzinga

Sat, 11/23/19 - 04:20 pm

With Cell-By-Cell Take on Drug Discovery, Immunitas Debuts With $39M

Xconomy

Thu, 11/21/19 - 11:34 pm

Immunitas Therapeutics

single-cell genomics

Pages